Our first Florida dispensary opening represents a significant milestone for our company and Florida patients.
SARASOTA, Fla. (PRWEB) June 21, 2018
AltMed Florida has announced the opening of the first of 25 MÜV™ dispensary locations at 5909 N US Hwy 41, Apollo Beach - strategically located to serve Apollo Beach, the entire Tampa Bay area, including Hillsborough, Pinellas and Manatee county markets.
The Grand Opening is Saturday, June 23rd from 10am-7pm for licensed Florida medical cannabis patients.
Located just a few hundred yards south of Apollo Beach Blvd on US Highway 41, the site has easily accessible roadside visibility and a dedicated parking lot.
“Our first Florida dispensary opening represents a significant milestone for our company and Florida patients,” said AltMed Florida CEO John Tipton. “Our MÜV Medical Cannabis line of products already has a wide following in other legal medical cannabis markets, including Arizona, where it has won Five Best of Arizona medical cannabis awards.”
MÜV Products offer an extensive variety of delivery options, including several that are unique among current Florida license holders with its patent-pending transdermal gels and metered dose inhalers. Products will come high in CBD or THC as well as CBD/THC balanced formulations. Product categories will include topicals (gels and creams), transdermal patches, metered dose inhalers, distillate vaporizer pens (without any cutting agents), all-natural terpene enriched vaporizer pens, strain specific vaporizer pens, oral sprays, tinctures and an Activated Metered click distillate syringe.
MÜV Products will be sold exclusively in Florida at MÜV dispensaries because, unlike other states, Florida does not allow wholesale of product between license holders - only products that license holders make themselves can be sold in their dispensaries.
“The MÜV retail experience speaks to the role of medical cannabis products in the modern healthcare marketplace,” said AltMed Marketing Director Todd Beckwith. “We learned that MÜV customers in other legal medical cannabis states are more apt to take an active role in their healthcare than with traditional medicine. They want to understand the products and the research behind the products, so we have created a layered and informative retail experience.”
For more information about the new ADA compliant Apollo Beach MÜV Medical Cannabis Dispensary, including hours and available MÜV products, visit: http://www.altmedflorida.com.
About AltMed Enterprises - Alternative Medical Enterprises, LLC, headquartered in Sarasota, FL and doing business as AltMed Enterprises, is a fully integrated company that brings pharmaceutical industry precision to the development, production and dispensing of medical cannabinoids.
About AltMed Florida, LLC (Plants of Ruskin, LLC d.b.a.) - With a focus on quality and attention to detail, Plants of Ruskin has more than 35 years of experience in providing seedlings to farmers for vegetable and medical product production. Plants of Ruskin founders, the Dickman Family, are 4th generation farmers with a long history of working in conjunction with the University of Florida, including an endowed chair specifically dedicated to plant improvement.
About MÜV™ - The MÜV brand of cannabis infused products was launched in Arizona in 2016 and has quickly gained international attention and recognition. In its first six months alone, MÜV received four best of Arizona medical cannabis awards, including two first prizes for its proprietary extractions that are the basis of all MÜV products.
Forward-Looking Statements - To the extent any statements made in this press release contain information that is not historical, these statements are forward-looking in nature and merely express our beliefs, expectations or opinions. For example, words such as “may,” “should,” “estimates,” “predicts,” “continues,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “potential,” “strategy” and similar expressions are intended to identify forward-looking statements. Such statements are based on current expectations or estimates and involve a number of known and unknown risks and uncertainties that could cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, the following: (i) our ability to implement our business strategy of distributing high quality cannabis products where permissible under applicable law; (ii) availability and cost of additional capital; (iii) our ability to attract, retain and motivate qualified employees and management; (iv) the impact of federal, state or local government regulations; (v) competition in the cannabis industry; (vi) our ability to generate revenues; and (vii) litigation in connection with our business. All forward-looking statements included in this press release and attributable to us or any person acting on our behalf are qualified by this cautionary statement. Forward-looking statements speak only as of the date on which they are made, and, except as required by law, we undertake no obligation to update or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise.
